Ani Pharmaceuticals Inc (ANIP)
Cost of Revenue
$340.18M
TTM · Period ending: · USD
ANIP Cost of Revenue
Latest reported$340.18Mperiod ending
Latest reported$340.18Mperiod ending
ANIP Cost of Revenue ($0.00 → $340.18M)
Annual cost of revenue
High-resolution chart · PNG
ANIP cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 432,727,000 | |
| 250,210,000 | |
| 181,513,000 | |
| 138,785,000 | |
| 100,610,000 | |
| 87,157,000 | |
| 63,154,000 | |
| 73,024,000 | |
| 79,032,000 | |
| 48,780,000 | |
| 12,692,000 | |
| 11,473,000 | |
| 9,974,000 | |
| 9,167,000 | |
| 50,000 | |
| 268,750 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -24,290 | |
| 0 | |
| 0 |